Abstract Details
|
Jay Salpekar
PRESENTER |
No disclosure on file |
| Cynthia L. Harden, MD (Xenon Pharmaceuticals Inc) | Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care. |
| David W. Loring, PhD, FAAN (Emory Univ, Dept of Neurology) | Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE. The institution of Dr. Loring has received research support from NIH. Dr. Loring has received publishing royalties from a publication relating to health care. |
| Todd Grinnell, PhD | Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc.. |
| David Cantu, PhD (Sunovion Pharmaceuticals Inc.) | Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc.. |
| No disclosure on file | |
| No disclosure on file |